International Journal of Molecular Sciences, Journal Year: 2025, Volume and Issue: 26(6), P. 2428 - 2428
Published: March 8, 2025
Mild cognitive impairment (MCI) is a clinical condition characterized by decline in ability and progression of impairment. It often considered transitional stage between normal aging Alzheimer’s disease (AD). This study aimed to compare deep learning (DL) traditional machine (ML) methods predicting MCI using plasma proteomic biomarkers. A total 239 adults were selected from the Disease Neuroimaging Initiative (ADNI) cohort along with pool 146 We evaluated seven ML models (support vector machines (SVMs), logistic regression (LR), naïve Bayes (NB), random forest (RF), k-nearest neighbor (KNN), gradient boosting (GBM), extreme (XGBoost)) six variations neural network (DNN) model—the DL model H2O package. Least Absolute Shrinkage Selection Operator (LASSO) 35 biomarkers pool. Based on grid search, DNN an activation function “Rectifier With Dropout” 2 layers 32 revealed best highest accuracy 0.995 F1 Score 0.996, while among methods, XGBoost was 0.986 0.985. Several correlated APOE-ε4 genotype, polygenic hazard score (PHS), three cerebrospinal fluid (Aβ42, tTau, pTau). Bioinformatics analysis Gene Ontology (GO) Kyoto Encyclopedia Genes Genomes (KEGG) several molecular functions pathways associated biomarkers, including cytokine-cytokine receptor interaction, cholesterol metabolism, regulation lipid localization. The results showed that may represent promising tool prediction MCI. These help early diagnosis, prognostic risk stratification, treatment interventions for individuals at
Language: Английский